SMILES,Name,Conditions,NCT_Number,Phases,Unapproval Probability,Approval Probability
C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,_ESTRADIOL,URINARY TRACT INFECTIONS,NCT04301934,Not Applicable,0.13065473335713362,0.8693452666428665
CC(=O)[O-],_ACETATE,DEPRESSION,NCT02837432,Early Phase 1,0.5394196795558187,0.4605803204441814
CC(=O)[O-],_ACETATE,BURN,NCT01413620,Phase 1,0.4919644206503359,0.5080355793496644
C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,_EXEMESTANE,NON SMALL CELL LUNG CANCER,NCT02666105,Phase 2,0.3519615546913256,0.6480384453086745
C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12,_EXEMESTANE,OVARIAN CANCER,NCT04460807,Phase 3,0.13647067389966824,0.863529326100332
C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O,_FULVESTRANT,NEOPLASMS,NCT02530411,Phase 2,0.5843521261987864,0.4156478738012136
N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1,_LETROZOLE,OVARIAN CANCER,NCT03378297,Early Phase 1,0.21514511494206645,0.7848548850579335
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.00044427430368745597,0.9995557256963126
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,VASCULITIS,NCT03692416,Phase 3,0.00044427430368745597,0.9995557256963126
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,COVID-19,NCT04451174,Phase 3,0.00044427430368745597,0.9995557256963126
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISONE,AIRWAY INFLAMMATION,NCT03861390,Phase 1|Phase 2,0.09791285950449438,0.9020871404955056
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NEOPLASMS,NCT03693612,Phase 2,0.08399710958665213,0.916002890413348
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C,_DOCETAXEL,NON-SMALL CELL LUNG CANCER METASTATIC,NCT04154956,Phase 3,0.06531112087010471,0.9346888791298952
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,PROSTATE CANCER,NCT04194554,Phase 1|Phase 2,0.3758265719502235,0.6241734280497766
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,BREAST CANCER,NCT02826512,Phase 2,0.3467743927132041,0.653225607286796
NC(=O)c1cccc2cn(-c3ccc([C@@H]4CCCNC4)cc3)nc12,_NIRAPARIB,LUNG CANCER,NCT03891615,Phase 1,0.39085802828150135,0.6091419717184986
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,OVARIAN CANCER,NCT03464201,Phase 2,0.4686232060179971,0.5313767939820029
CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,_ENZALUTAMIDE,BREAST CANCER,NCT02955394,Phase 2,0.3928956225851555,0.6071043774148446
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.26573951682747604,0.7342604831725239
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,NEOPLASMS,NCT03967223,Phase 2,0.17990948687522826,0.8200905131247719
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.0680378592788757,0.9319621407211244
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,PROSTATE CANCER,NCT03089203,Phase 1,0.2793209959795364,0.7206790040204636
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,HEMATOLOGICAL MALIGNANCY,NCT03344705,Phase 1,0.2397112500179233,0.7602887499820767
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,HEPATOCELLULAR CARCINOMA,NCT04011033,Phase 2|Phase 3,0.06553757501089905,0.9344624249891008
O=P1(N(CCCl)CCCl)NCCCO1,_CYCLOPHOSPHAMIDE,MULTIPLE SCLEROSIS,NCT03477500,Phase 3,0.0630378592788757,0.9369621407211244
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,VASCULITIS,NCT03692416,Phase 3,0.05262086292070253,0.9473791370792974
CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1,_METHOTREXATE,BREAST CANCER,NCT02897700,Phase 1,0.036926485404478994,0.9630735145955208
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,_TACROLIMUS,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.3157799126102666,0.6842200873897332
CS(=O)(=O)OCCCCOS(C)(=O)=O,_BUSULFAN,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.6147537120940917,0.3852462879059082
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,OVARIAN CANCER,NCT03814447,Early Phase 1,0.6450058305518676,0.35499416944813234
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,NEOPLASMS,NCT03967223,Phase 2,0.7391025046592261,0.2608974953407737
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,HEMATOLOGICAL MALIGNANCY,NCT03344705,Phase 1,0.6601127360025226,0.3398872639974773
Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,_FLUDARABINE,HEPATOCELLULAR CARCINOMA,NCT02905188,Phase 1,0.8985498167020942,0.10145018329790564
CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F,_CAPECITABINE,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.7111993970176749,0.288800602982325
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,OVARIAN CANCER,NCT03936270,Phase 2,0.5615471159833051,0.4384528840166951
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,PROSTATE CANCER,NCT02905318,Phase 2,0.5694450112414061,0.4305549887585938
CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,_PALBOCICLIB,LUNG CANCER,NCT03170206,Phase 1|Phase 2,0.6126893943313197,0.38731060566868014
CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1,_ANASTROZOLE,PULMONARY ARTERIAL HYPERTENSION,NCT03229499,Phase 2,0.4940221346440588,0.5059778653559411
CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2,_VINORELBINE,LUNG ADENOCARCINOMA,NCT03891173,Phase 2,0.270012506151456,0.7299874938485441
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,LUNG CANCER,NCT02428764,Phase 2,0.1950515619561181,0.804948438043882
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1,_GEMCITABINE,METASTATIC BREAST CANCER,NCT03901339,Phase 3,0.1989126367908834,0.8010873632091166
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NON SMALL CELL LUNG CANCER,NCT02477826,Phase 3,0.129716737344429,0.8702832626555711
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,NEOPLASMS,NCT03693612,Phase 2,0.1342342012243561,0.8657657987756441
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,SMALL CELL LUNG CANCER,NCT04210037,Phase 1|Phase 2,0.17498611440560502,0.8250138855943949
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER,NCT04416035,Phase 3,0.09995942565183284,0.9000405743481673
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,ADVANCED NON-SQUAMOUS NSCLC,NCT04325698,Phase 3,0.09995942565183284,0.9000405743481673
CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,_PACLITAXEL,SQUAMOUS CELL CARCINOMA,NCT03719924,Phase 2,0.08354170624089048,0.9164582937591096
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,NON SMALL CELL LUNG CANCER,NCT03334617,Phase 2,0.8026325680766955,0.1973674319233044
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,OVARIAN CANCER,NCT03378297,Early Phase 1,0.6022300029502348,0.3977699970497651
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,PROSTATE CANCER,NCT03810105,Phase 2,0.8027286915399777,0.19727130846002225
O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1,_OLAPARIB,PULMONARY ARTERIAL HYPERTENSION,NCT03782818,Phase 1|Phase 2,0.8904127912708242,0.10958720872917553
Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,_ENTINOSTAT,NEUROENDOCRINE TUMORS,NCT03211988,Phase 2,0.7932711567498409,0.20672884325015894
NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC1=O.NCCCCC(NC(=O)C1CCCN1C(=O)C1CSSCC(N)C(=O)NC(Cc2ccc(O)cc2)C(=O)NC(Cc2ccccc2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(N)=O)C(=O)N1)C(=O)NCC(N)=O,_VASOPRESSIN,HYPERTENSION,NCT04170751,Not Applicable,0.7397882328688538,0.2602117671311461
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,NON SMALL CELL LUNG CANCER,NCT03661567,Phase 2,0.0011892101473357708,0.9988107898526642
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.003380473670503764,0.9966195263294962
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,COVID-19,NCT04329650,Phase 2,0.003380473670503764,0.9966195263294962
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,PNEUMONIA,NCT03852537,Phase 2,0.02584627376729233,0.9741537262327078
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,_METHYLPREDNISOLONE,COVID-19 PNEUMONIA,NCT04438980,Phase 3,0.003380473670503764,0.9966195263294962
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,LATERAL EPICONDYLITIS,NCT04201249,Phase 2|Phase 3,0.016009901070481166,0.9839900989295188
CCN(CC)CC(=O)Nc1c(C)cccc1C,_LIDOCAINE,COUGH,NCT03805282,Phase 3,0.0019458887968035925,0.9980541112031964
O=C([O-])c1ccccc1-c1c2cc(Br)c(=O)c(Br)c-2oc2c(Br)c([O-])c(Br)cc12.[Na+].[Na+],_EOSIN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT04008017,,0.32770522493711896,0.6722947750628809
NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,_AMIKACIN,PNEUMONIA VENTILATOR ASSOCIATED,NCT03149640,Phase 3,0.0855502031799077,0.9144497968200922
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12,_MEROPENEM,"TUBERCULOSIS, PULMONARY",NCT03174184,Phase 2,0.008544472024768797,0.9914555279752312
C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,_CYCLOSPORINE,COVID-19,NCT04412785,Phase 1,0.36075584333065336,0.6392441566693466
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03492255,Not Applicable,0.11973278130040953,0.8802672186995906
COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2,_MYCOPHENOLATE_MOFETIL,HEMATOLOGICAL MALIGNANCY,NCT01349101,Phase 2,0.30703907316670603,0.6929609268332939
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,COVID-19,NCT04341675,Phase 2,0.19123167954762613,0.8087683204523737
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,ISCHEMIC HEART DISEASE,NCT03600961,,0.2998531099144984,0.7001468900855015
CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,_SIROLIMUS,SARS-COV-2|COVID-19,NCT04371640,Phase 1,0.19123167954762613,0.8087683204523737
N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O,_MELPHALAN,NON-CYSTIC FIBROSIS BRONCHIECTASIS,NCT04278040,Phase 2,0.6364538278627581,0.3635461721372419
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)[CH]CC2=O)C(C)C)cc1)C(C)C,_VEDOTIN,NON SMALL CELL LUNG CANCER,NCT03539536,Phase 2,0.7313926054081334,0.2686073945918668
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,DEPRESSION,NCT02837432,Early Phase 1,0.08383965200683254,0.9161603479931674
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,PROSTATE CANCER,NCT00859781,Phase 2,0.2568631788793879,0.7431368211206123
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,SEPSIS,NCT04160676,Not Applicable,0.04908057456764061,0.9509194254323596
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_HYDROCORTISONE,COMMUNITY ACQUIRED PNEUMONIA,NCT02517489,Phase 3,0.04908057456764061,0.9509194254323596
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,_ETOPOSIDE,NON SMALL CELL LUNG CANCER,NCT03840902,Phase 2,0.31158142225607016,0.6884185777439299
COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O,_ETOPOSIDE,COVID-19,NCT04356690,Phase 2,0.3026860299247942,0.697313970075206
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,_PREDNISOLONE,ASTHMA IN CHILDREN,NCT03962894,,0.1015117704677382,0.8984882295322617
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,PROSTATE CANCER,NCT03513211,Phase 1|Phase 2,0.09040677837687797,0.909593221623122
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.2686117065779668,0.7313882934220335
CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_HYDROXYCHLOROQUINE,TYPE 1 DIABETES,NCT03428945,Phase 2,0.10679647007652912,0.8932035299234709
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04165096,Phase 2,0.11013274190852926,0.8898672580914709
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.1078111902121302,0.8921888097878697
CC(=O)Nc1ccc(O)cc1,_ACETAMINOPHEN,ANALGESIA,NCT03955211,Phase 2,0.4155776014335103,0.5844223985664897
CN(C)CCOC(c1ccccc1)c1ccccc1,_DIPHENHYDRAMINE,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04165096,Phase 2,0.1143097511536462,0.8856902488463537
Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,_SELUMETINIB,NON SMALL CELL LUNG CANCER,NCT03392246,Phase 2,0.6200591541340313,0.3799408458659686
C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC1=O,_SOMATOSTATIN,HEPATOCELLULAR CARCINOMA,NCT02799212,Phase 3,0.2687725233534456,0.7312274766465543
CC(C)NCC(O)COc1cccc2ccccc12,_PROPRANOLOL,OBSTRUCTIVE SLEEP APNEA,NCT03049306,Phase 2,0.15785497401889795,0.8421450259811022
CC(=O)Nc1nnc(S(N)(=O)=O)s1,_ACETAZOLAMIDE,SMALL CELL LUNG CANCER,NCT03467360,Phase 1,0.16832537618086665,0.8316746238191334
CC(=O)Nc1nnc(S(N)(=O)=O)s1,_ACETAZOLAMIDE,"HYPOXIA, ALTITUDE",NCT04251364,Not Applicable,0.0014030845641092669,0.9985969154358908
CC(=O)Nc1nnc(S(N)(=O)=O)s1,_ACETAZOLAMIDE,"HYPERTENSION, PULMONARY",NCT02755298,Phase 2|Phase 3,0.008684008216953414,0.9913159917830466
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,MULTIPLE SCLEROSIS,NCT04035889,Not Applicable,0.4299741942987326,0.5700258057012675
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,OBSTRUCTIVE SLEEP APNEA,NCT02484300,Not Applicable,0.4356853153336061,0.5643146846663941
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,MECHANICALLY VENTILATED PATIENTS,NCT03524937,Phase 2|Phase 3,0.3589529848031409,0.6410470151968594
COc1ccc2[nH]cc(CCNC(C)=O)c2c1,_MELATONIN,MIGRAINE DISORDERS,NCT03597529,Phase 2,0.5174233288181455,0.4825766711818542
Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1,_FOLIC_ACID,ANEMIA,NCT04404751,Not Applicable,0.5064387001210673,0.4935612998789326
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,_AZITHROMYCIN,BACTERIAL INFECTIONS,NCT03925480,Phase 3,0.005,0.995
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,_AZITHROMYCIN,LOWER RESPIRATORY TRACT INFECTION,NCT03341273,Not Applicable,0.06110381806871211,0.9388961819312877
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,_AZITHROMYCIN,INTUBATION COMPLICATION,NCT03250975,Phase 1|Phase 2,0.013394383172657804,0.9866056168273424
NC(=O)c1cccnc1,_NICOTINAMIDE,HYPERTENSION,NCT04112043,Phase 1,0.5332931457870383,0.4667068542129617
NC(=O)c1cccnc1,_NIACINAMIDE,HYPERTENSION,NCT04112043,Phase 1,0.5332931457870383,0.4667068542129617
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,OVARIAN CANCER,NCT03924882,Phase 2,0.1685726089402959,0.8314273910597039
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,LUNG CANCER,NCT03983928,Phase 1|Phase 2,0.15245551907401672,0.8475444809259832
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,HEPATOCELLULAR CARCINOMA,NCT03945799,Phase 1|Phase 2,0.09247536901071186,0.9075246309892879
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1,_ANLOTINIB,LUNG NEOPLASMS,NCT03940404,,0.2048798943274042,0.7951201056725961
NC(=O)CC[C@H](N)C(=O)O,_GLUTAMINE,BURN,NCT00985205,Phase 3,0.6482063978235745,0.35179360217642514
NC(=O)CC[C@H](N)C(=O)O,_L-GLUTAMINE,BURN,NCT00985205,Phase 3,0.6482063978235745,0.35179360217642514
CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl,_AMLODIPINE,"OBESITY, MORBID",NCT02904291,,0.2414087863221321,0.7585912136778681
O=C1O[C@H]([C@@H](O)CO)C(O)=C1O,_ASCORBIC_ACID,SEPSIS,NCT04160676,Not Applicable,0.15440751121499674,0.8455924887850036
Cn1nnc2c(C(N)=O)ncn2c1=O,_TEMOZOLOMIDE,SMALL CELL LUNG CANCER,NCT04400188,Phase 1|Phase 2,0.8118087134015346,0.18819128659846532
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,_SUNITINIB,BREAST CANCER,NCT02790580,Phase 2,0.2134678938883008,0.7865321061116994
N[C@@H](Cc1ccc(O)cc1)C(=O)O,_TYROSINE,"CARCINOMA, NON-SMALL-CELL LUNG",NCT03799094,Phase 1|Phase 2,0.3594221525520508,0.6405778474479494
N[C@@H](Cc1ccc(O)cc1)C(=O)O,_TYROSINE,NSCLC,NCT04318938,Phase 2,0.35572043811648585,0.6442795618835143
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,COVID-19,NCT04377620,Phase 3,0.7526100451074423,0.24738995489255736
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,_RUXOLITINIB,CORONAVIRUS INFECTION,NCT04348695,Phase 2,0.6377524107248957,0.3622475892751042
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,_DOXORUBICIN,METASTATIC BREAST CANCER,NCT04159818,Phase 2,0.3171416356460697,0.6828583643539307
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl,_DOXORUBICIN_HYDROCHLORIDE,OVARIAN CANCER,NCT04337632,Phase 3,0.30594590142145445,0.6940540985785455
O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O,_ZOLEDRONIC_ACID,"CARCINOMA, NON-SMALL-CELL LUNG",NCT03958565,,0.37211558770781095,0.6278844122921893
COC(=O)C(c1ccccc1)C1CCCCN1,_METHYLPHENIDATE,"OBESITY, MORBID",NCT03440190,,0.22015655708979096,0.7798434429102091
COC(=O)C(c1ccccc1)C1CCCCN1,_METHYLPHENIDATE,ANXIETY,NCT02153944,Not Applicable,0.18929643406387472,0.8107035659361252
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,_AFATINIB,LUNG CANCER,NCT01553942,Phase 2,0.3870944867068631,0.6129055132931369
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,LIVER CIRRHOSIS,NCT02642874,Phase 3,0.1396859513076266,0.8603140486923735
O=C([O-])[O-].[Ca+2],_CALCIUM_CARBONATE,OSTEOPOROSIS,NCT04550078,Not Applicable,0.32257250409755145,0.6774274959024486
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03953261,Phase 2,0.1883026919386328,0.8116973080613674
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,PROSTATE CANCER,NCT03769766,Phase 3,0.19315685782439,0.8068431421756102
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,_CURCUMIN,BREAST CANCER,NCT03980509,Phase 1,0.5691486932499472,0.4308513067500527
CC(=O)N[C@@H](CS)C(=O)O,_ACETYLCYSTEINE,IDIOPATHIC PULMONARY FIBROSIS,NCT04312594,Phase 2,0.13623979131306269,0.8637602086869375
N[C@@H](CS)C(=O)O,_CYSTEINE,COVID-19,NCT04370288,Phase 1,0.1870365888241348,0.8129634111758651
N[C@@H](CS)C(=O)O,_CYSTEINE,"TUBERCULOSIS, PULMONARY",NCT03702738,Phase 2,0.1870365888241348,0.8129634111758651
Cn1c(=O)c2c(ncn2C)n(C)c1=O,_CAFFEINE,"PAIN, POSTOPERATIVE",NCT04280263,Not Applicable,0.07131463010898821,0.928685369891012
CC(C)C[C@H](N)C(=O)O,_LEUCINE,DEPRESSION,NCT03557684,Early Phase 1,0.6144522809736856,0.3855477190263145
Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2,_VITAMIN_E,BREAST CANCER,NCT04463459,Not Applicable,0.6725204498715113,0.3274795501284888
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,_CHOLECALCIFEROL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT04011930,Phase 2,0.08607887713764978,0.9139211228623504
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C,_CHOLECALCIFEROL,ATOPIC DERMATITIS,NCT02537509,Phase 2,0.06419617064648618,0.935803829353514
CN(C)C(=N)NC(=N)N,_METFORMIN,NON SMALL CELL LUNG CANCER,NCT03874000,Phase 2,0.25350017077905723,0.7464998292209429
CN(C)C(=N)NC(=N)N,_METFORMIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.2707783230898281,0.7292216769101719
CN(C)C(=N)NC(=N)N,_METFORMIN,BREAST CANCER,NCT04559308,Phase 2,0.1374394059115561,0.8625605940884441
CN(C)C(=N)NC(=N)N,_METFORMIN,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04170959,Phase 2,0.14219319446654827,0.8578068055334519
CN(C)C(=N)NC(=N)N,_METFORMIN,HEART FAILURE,NCT03331861,Phase 2,0.21211191344735272,0.7878880865526474
CN(C)C(=N)NC(=N)N,_METFORMIN,RHEUMATOID ARTHRITIS,NCT04068246,Early Phase 1,0.14219319446654827,0.8578068055334519
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NEOPLASMS,NCT02964013,Phase 1,0.21783693466985504,0.782163065330145
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NON-SMALL CELL LUNG CANCER METASTATIC,NCT04163432,Phase 2,0.2859651717778697,0.7140348282221305
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,LUNG CANCER,NCT01553942,Phase 2,0.3152333338953422,0.6847666661046579
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,LUNG NEOPLASMS,NCT03380468,Phase 2|Phase 3,0.026650743576917817,0.973349256423082
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,NON-SQUAMOUS NSCLC,NCT03802240,Phase 3,0.1473813513924429,0.8526186486075572
Nc1nc(=O)c2c(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c[nH]c2[nH]1,_PEMETREXED,CARCINOMA|NON-SMALL-CELL LUNG,NCT03952403,Phase 3,0.1473813513924429,0.8526186486075572
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,OVARIAN CANCER,NCT03378297,Early Phase 1,0.20849507895337904,0.7915049210466211
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,COVID-19,NCT04333407,Not Applicable,0.04464498819338537,0.9553550118066148
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,SEPSIS,NCT01784159,Phase 2,0.0416643021975013,0.9583356978024986
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.13392293953202822,0.8660770604679721
CC(=O)Oc1ccccc1C(=O)O,_ASPIRIN,AORTIC STENOSIS,NCT03557242,Not Applicable,0.11102375794178787,0.8889762420582121
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,OVARIAN CANCER,NCT03378297,Early Phase 1,0.20849507895337904,0.7915049210466211
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,COVID-19,NCT04333407,Not Applicable,0.04464498819338537,0.9553550118066148
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,SEPSIS,NCT01784159,Phase 2,0.0416643021975013,0.9583356978024986
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,MULTIPLE SCLEROSIS,NCT03824938,Phase 1|Phase 2,0.13392293953202822,0.8660770604679721
CC(=O)Oc1ccccc1C(=O)O,_ACETYLSALICYLIC_ACID,AORTIC STENOSIS,NCT03557242,Not Applicable,0.11102375794178787,0.8889762420582121
CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O,_PENTOXIFYLLINE,SCHIZOPHRENIA,NCT04094207,Phase 1|Phase 2,0.2576654727500621,0.742334527249938
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,COVID-19,NCT04333407,Not Applicable,0.14266035913753347,0.8573396408624668
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,BREAST CANCER,NCT02958852,Phase 2,0.13199347667366798,0.8680065233263322
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,"SLEEP APNEA, OBSTRUCTIVE",NCT03308578,Phase 1|Phase 2,0.3652463549950661,0.6347536450049339
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,"HYPOXIA, ALTITUDE",NCT04251364,Not Applicable,0.12467722550093775,0.8753227744990625
CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,_ATORVASTATIN,OBSTRUCTIVE SLEEP APNEA OF ADULT,NCT03122639,Early Phase 1,0.3652463549950661,0.6347536450049339
CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)O)C(C)C,_VALSARTAN,"OBESITY, MORBID",NCT03535376,,0.2307267329878772,0.7692732670121226
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,_FEXOFENADINE,GASTROESOPHAGEAL REFLUX,NCT03425097,Phase 2,0.0768607769420753,0.9231392230579248
CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C,_ANGIOTENSIN,RHEUMATOID ARTHRITIS,NCT03770702,Phase 3,0.1324401319185675,0.8675598680814325
O=c1[nH]cc(F)c(=O)[nH]1,_FLUOROURACIL,BREAST CANCER,NCT02897700,Phase 1,0.6049665817069646,0.3950334182930352
CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC.Cl.O.O.O,_IRINOTECAN_HYDROCHLORIDE,SMALL CELL LUNG CANCER,NCT04381910,Phase 2,0.6279559524594628,0.3720440475405371
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,_ATP,COUGH,NCT03722849,Not Applicable,0.541888871517271,0.4581111284827289
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O,_ADENOSINE_TRIPHOSPHATE,COUGH,NCT03722849,Not Applicable,0.541888871517271,0.4581111284827289
COCCc1ccc(OCC(O)CNC(C)C)cc1,_METOPROLOL,"OBESITY, MORBID",NCT03519906,,0.15947823627056198,0.8405217637294381
COc1ccc2nc(S(=O)Cc3ncc(C)c(OC)c3C)[nH]c2c1,_OMEPRAZOLE,COVID-19,NCT04333407,Not Applicable,0.03527154357209508,0.9647284564279048
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,"SLEEP APNEA, OBSTRUCTIVE",NCT03545997,Phase 3,0.004517463879927058,0.9954825361200731
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,_MONTELUKAST,PAIN,NCT02793375,Phase 3,0.025596394639210814,0.9744036053607892
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2,_MIDAZOLAM,BREAST CANCER,NCT04172220,Not Applicable,0.012984206270171912,0.987015793729828
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,_ROSUVASTATIN,OVARIAN CANCER,NCT03532139,Phase 2,0.39631289472967707,0.6036871052703229
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21,_SIMVASTATIN,CORONAVIRUS INFECTION,NCT04348695,Phase 2,0.1858399176265608,0.8141600823734394
CCOC(=O)[C@H](C)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)CCC(=O)O,_SACUBITRIL,HYPERTROPHIC CARDIOMYOPATHY,NCT03832660,Phase 2,0.20971523384146,0.7902847661585402
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,COVID-19,NCT04366050,Phase 2,0.2385082127093341,0.7614917872906659
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21,_RAMIPRIL,"OBESITY, MORBID",NCT03440177,,0.24466692174283586,0.7553330782571642
[C-]#[O+],_CARBON_MONOXIDE,SMOKING CESSATION,NCT03059940,Early Phase 1,0.7397704126482479,0.2602295873517519
[C-]#[O+],_CARBON_MONOXIDE,ACUTE RESPIRATORY DISTRESS SYNDROME,NCT03799874,Phase 2,0.7397704126482479,0.2602295873517519
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,BREAST CANCER,NCT03109990,Not Applicable,0.005573915433535657,0.9944260845664644
Cc1cccc([C@H](C)c2c[nH]cn2)c1C,_DEXMEDETOMIDINE,ANALGESIA,NCT04442906,Not Applicable,0.008757735488106837,0.9912422645118932
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,_BORTEZOMIB,HEMATOLOGICAL MALIGNANCY,NCT03850366,Phase 2,0.9219607084211796,0.07803929157882064
Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1,_CELECOXIB,ANALGESIA,NCT03974932,Phase 3,0.3914863884815529,0.6085136115184472
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,_IMATINIB,COVID-19 PNEUMONIA,NCT04346147,Phase 2,0.2710935668478069,0.7289064331521931
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,COVID-19,NCT04335123,Phase 1,0.3661527367671838,0.6338472632328164
CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1,_LOSARTAN,"OBESITY, MORBID",NCT03519893,,0.17387895879218526,0.8261210412078147
O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1,_COBIMETINIB,NON SMALL CELL LUNG CANCER,NCT03178552,Phase 2|Phase 3,0.6141056430218895,0.3858943569781104
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,_CABOZANTINIB,NON SMALL CELL LUNG CANCER,NCT04131543,Phase 2,0.6932158672673319,0.3067841327326682
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,_CABOZANTINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04471428,Phase 3,0.5412844240256521,0.4587155759743479
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,NON SMALL CELL LUNG CANCER,NCT03087448,Phase 1|Phase 2,0.4991715293992362,0.5008284706007637
CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1,_TRAMETINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04452877,Phase 2,0.2841742673464808,0.7158257326535198
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,_DABRAFENIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT04452877,Phase 2,0.25633873086432124,0.7436612691356789
C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,_LORLATINIB,NON SMALL CELL LUNG CANCER,NCT02927340,Phase 2,0.3185200737050212,0.6814799262949789
C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,_LORLATINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT03052608,Phase 3,0.3492779513366921,0.650722048663308
C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,_LORLATINIB,ADVANCED CANCERS,NCT03726333,Phase 1,0.3900522358300762,0.6099477641699237
O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1,_SELINEXOR,NON SMALL CELL LUNG CANCER,NCT03095612,Phase 1|Phase 2,0.9185840367363532,0.08141596326364665
O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1,_SELINEXOR,CORONAVIRUS INFECTION,NCT04349098,Phase 2,0.6839019045251057,0.3160980954748943
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,_THALIDOMIDE,THALASSEMIA,NCT03651102,Phase 2|Phase 3,0.3256670742822315,0.6743329257177686
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,_IBRUTINIB,PROSTATE CANCER,NCT02643667,Phase 1|Phase 2,0.7015210569996451,0.298478943000355
C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21,_DOXYCYCLINE,INFERTILITY,NCT03824340,Not Applicable,0.009602635648625766,0.9903973643513744
CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,_TOPIRAMATE,SCHIZOPHRENIA,NCT02808533,Not Applicable,0.18749663780187573,0.8125033621981242
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,COVID-19,NCT04350593,Phase 3,0.2868250587333732,0.7131749412666271
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,TYPE 1 DIABETES,NCT03899402,Phase 2|Phase 3,0.3066737258649294,0.6933262741350706
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,AGING,NCT04401904,Phase 1|Phase 2,0.3066737258649294,0.6933262741350706
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,_DAPAGLIFLOZIN,"HEART FAILURE, DIASTOLIC",NCT04475042,Phase 2,0.2932058781188123,0.7067941218811878
O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl,_DICLOFENAC,BREAST CANCER,NCT04511832,Not Applicable,0.1992702930774723,0.8007297069225278
CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5,_BUPRENORPHINE,"OBESITY, MORBID",NCT03460314,,0.26085067771575715,0.7391493222842427
COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314,_CODEINE,CHRONIC HEART FAILURE,NCT04332536,Not Applicable,0.09728595179874863,0.9027140482012516
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,VASCULITIS,NCT03692416,Phase 3,0.02727033575446073,0.9727296642455392
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,ANALGESIA,NCT03955211,Phase 2,0.40868103176288106,0.5913189682371189
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,PAIN|ANXIETY,NCT03953729,Early Phase 1,0.041597875247197616,0.9584021247528024
CC(C)Cc1ccc(C(C)C(=O)O)cc1,_IBUPROFEN,"OBESITY, MORBID",NCT03476577,,0.2261698330050776,0.7738301669949224
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC,_TRIMETHOPRIM,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.4822883945040972,0.5177116054959028
C[C@@H](c1ncncc1F)[C@](O)(Cn1cncn1)c1ccc(F)cc1F,_VORICONAZOLE,INVASIVE PULMONARY ASPERGILLOSIS,NCT03672292,Phase 2,0.4464339171348473,0.5535660828651526
O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,_CIPROFLOXACIN,PNEUMONIA,NCT03177720,Phase 1,0.0275915161326939,0.9724084838673062
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,_AMOXICILLIN,INFECTION,NCT03844776,Not Applicable,0.059515164823598574,0.9404848351764012
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O,_AMOXICILLIN,"TUBERCULOSIS, PULMONARY",NCT03174184,Phase 2,0.0018473588677967226,0.9981526411322034
Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21,_BINIMETINIB,NON SMALL CELL LUNG CANCER,NCT03915951,Phase 2,0.779940775012963,0.22005922498703667
Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21,_BINIMETINIB,LUNG CANCER,NCT03170206,Phase 1|Phase 2,0.6750136926613645,0.32498630733863565
CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O,_WARFARIN,AORTIC STENOSIS,NCT03557242,Not Applicable,0.051615705922912564,0.9483842940770876
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,CYSTIC FIBROSIS,NCT04039087,Phase 2|Phase 3,0.009253403291066995,0.990746596708933
CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,_SILDENAFIL,BRONCHOPULMONARY DYSPLASIA,NCT03142568,Phase 2,0.10431296030869112,0.8956870396913088
COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,_APIXABAN,"OBESITY, MORBID",NCT03448783,,0.3053916273810391,0.694608372618961
CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O,_CALCITONIN,MIGRAINE DISORDERS,NCT04019496,,0.7220686637867537,0.2779313362132461
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_CHLOROQUINE,COVID-19 PNEUMONIA,NCT04428268,Phase 2,0.021688112801446127,0.978311887198554
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,_CHLOROQUINE,ATRIAL FIBRILLATION,NCT02932007,Phase 2,0.28314421515590626,0.7168557848440937
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O,_CHLOROQUINE_PHOSPHATE,COVID-19 PNEUMONIA,NCT04428268,Phase 2,0.06772856269876859,0.9322714373012316
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O,_CHLOROQUINE_PHOSPHATE,ATRIAL FIBRILLATION,NCT02932007,Phase 2,0.5700466672748672,0.4299533327251329
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C,_PROCALCITONIN,PNEUMONIA,NCT03711227,,0.7907526807356178,0.2092473192643822
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C,_PROCALCITONIN,LOWER RESPIRATORY TRACT INFECTION,NCT03341273,Not Applicable,0.7596986082074346,0.24030139179256524
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C,_PROCALCITONIN,"INFLUENZA, HUMAN",NCT02899065,Not Applicable,0.7185252608697553,0.2814747391302444
Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,_LOPINAVIR,COVID-19 PNEUMONIA,NCT04346147,Phase 2,0.06398290157518652,0.9360170984248134
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O,_RIFABUTIN,PULMONARY TUBERCULOSIS,NCT02256696,Phase 2,0.2009460903581931,0.7990539096418067
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,SCHIZOPHRENIA,NCT04369391,Phase 1,0.1626050375484023,0.8373949624515977
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,_MOXIFLOXACIN,DIABETES,NCT01984827,Phase 1,0.10971669506840756,0.8902833049315925
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCC/N=C/N)C[C@H]12,_IMIPENEM,PNEUMONIA,NCT03177720,Phase 1,0.05512409592409047,0.9448759040759094
O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,_ROFLUMILAST,ASTHMA,NCT04108377,Phase 1,0.04292650284419457,0.9570734971558056
[Cl-].[Na+],_SODIUM_CHLORIDE,COVID-19,NCT04364763,Phase 2,0.4048783781328597,0.5951216218671402
[Cl-].[Na+],_SODIUM_CHLORIDE,EPISTAXIS,NCT02930941,Not Applicable,0.18588047319951326,0.8141195268004866
[Cl-].[Na+],_SODIUM_CHLORIDE,ALLERGIC ASTHMA,NCT04035109,Phase 1|Phase 2,0.3768812987367819,0.6231187012632181
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,COVID-19,NCT04331470,Phase 2|Phase 3,0.0005973512881865228,0.9994026487118134
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,INTUBATION COMPLICATION,NCT03250975,Phase 1|Phase 2,0.006617622511602774,0.9933823774883972
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,CHRONIC SINUSITIS,NCT04163978,Phase 2,0.005597351288186523,0.9944026487118134
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,SINUSITIS,NCT03584178,Not Applicable,0.0005973512881865228,0.9994026487118134
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_BUDESONIDE,ACUTE ASTHMA,NCT04016220,Phase 1,0.0005973512881865228,0.9994026487118134
Cc1ncc([N+](=O)[O-])n1CCO,_METRONIDAZOLE,INFECTION,NCT03844776,Not Applicable,0.2309289476288467,0.7690710523711536
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,_RIVAROXABAN,COVID-19,NCT04333407,Not Applicable,0.0318665154204506,0.9681334845795494
O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,_RIVAROXABAN,LIVER CIRRHOSIS,NCT03005444,Not Applicable,0.01837798073904487,0.9816220192609552
COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1,_VENLAFAXINE,"OBESITY, MORBID",NCT03532477,,0.1400506040105161,0.8599493959894841
CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21,_ESCITALOPRAM,"OBESITY, MORBID",NCT03460379,,0.22464394594091144,0.7753560540590886
NCC1(CC(=O)O)CCCCC1,_GABAPENTIN,"OBESITY, MORBID",NCT03476538,,0.22344197601711765,0.7765580239828823
C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12,_ERTAPENEM,URINARY TRACT INFECTIONS,NCT03218800,Phase 3,0.07121531319414054,0.9287846868058592
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,_LEVOFLOXACIN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT02067780,Phase 2,0.00964127410091273,0.9903587258990872
Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,_LAMOTRIGINE,"OBESITY, MORBID",NCT03497143,,0.3012826559136801,0.6987173440863201
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_MINOCYCLINE,HYPERTENSION,NCT02133872,Phase 1,0.224006058066419,0.775993941933581
CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O,_MINOCYCLINE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.3169230441472215,0.6830769558527785
COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O,_CAPSAICIN,COUGH,NCT03722849,Not Applicable,0.10569593564723627,0.8943040643527637
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1,_NITAZOXANIDE,COVID-19,NCT04463264,Phase 2|Phase 3,0.3205331223361162,0.6794668776638838
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,_COLCHICINE,COVID-19,NCT04360980,Phase 2,0.38130185051335547,0.6186981494866446
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,_COLCHICINE,CORONAVIRUS INFECTION,NCT04363437,Phase 2,0.5099347431912996,0.4900652568087004
COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,_COLCHICINE,CORONA VIRUS INFECTION,NCT04322682,Phase 3,0.6751102596577314,0.3248897403422684
CC(C)Cn1cnc2c(N)nc3ccccc3c21,_IMIQUIMOD,METASTATIC BREAST CANCER,NCT03982004,Phase 1,0.5372710384232646,0.4627289615767354
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,PROSTATE CANCER,NCT02944201,Phase 2,0.3029576419406128,0.6970423580593874
COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,_CARVEDILOL,BREAST CANCER,NCT03879629,Phase 2,0.17124953860917536,0.8287504613908245
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,HEART FAILURE,NCT02421341,Not Applicable,0.009090715159020449,0.9909092848409794
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,_FENTANYL,ANALGESIA,NCT04442906,Not Applicable,0.007031116051891815,0.992968883948108
FCOC(C(F)(F)F)C(F)(F)F,_SEVOFLURANE,ATRIAL FIBRILLATION,NCT02697448,Not Applicable,0.007191263523167994,0.992808736476832
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C,_BUPIVACAINE,ANALGESIA,NCT03922048,Phase 2,0.18763926460526897,0.8123607353947311
CC(C)c1cccc(C(C)C)c1O,_PROPOFOL,ATRIAL FIBRILLATION,NCT02697448,Not Applicable,0.0021912635231679935,0.997808736476832
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,ASTHMA IN CHILDREN,NCT04002362,Phase 2,0.2115994884835089,0.7884005115164912
C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,_TRIAMCINOLONE,PSORIASIS,NCT04117919,Phase 2,0.01864099386871833,0.9813590061312816
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,_TRIAMCINOLONE_ACETONIDE,ASTHMA IN CHILDREN,NCT04002362,Phase 2,0.3584863979214086,0.6415136020785914
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,_PIOGLITAZONE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.3163686681581259,0.6836313318418742
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,POSTOPERATIVE PAIN,NCT03011307,Phase 2,0.5939603647958173,0.4060396352041826
CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O,_OXYTOCIN,SLEEP APNEA,NCT02564068,Early Phase 1,0.6019871350192365,0.3980128649807635
C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1,_ROCURONIUM,PROSTATE CANCER,NCT03808077,Phase 2,0.13287566290955152,0.8671243370904486
Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314,_NALBUPHINE,POSTOPERATIVE COMPLICATIONS,NCT03470077,Phase 2,0.04991542652898386,0.9500845734710162
C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5,_NALOXONE,PAIN,NCT04034004,Early Phase 1,0.14206280696869966,0.8579371930313004
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,BURN,NCT03513406,Phase 3,0.052747493787174936,0.9472525062128249
CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1,_NEOSTIGMINE,POSTOPERATIVE PAIN,NCT04544228,Not Applicable,0.03177237857675618,0.9682276214232436
COc1cc(CC(C)N)c(OC)cc1C,_DOM,STROKE,NCT03828851,Not Applicable,0.15508007286530956,0.8449199271346904
NC[C@H]1CC[C@H](C(=O)O)CC1,_TRANEXAMIC_ACID,COVID-19,NCT04338074,Phase 2,0.11916299695216866,0.8808370030478314
NC[C@H]1CC[C@H](C(=O)O)CC1,_TRANEXAMIC_ACID,EPISTAXIS,NCT02930941,Not Applicable,0.11916299695216866,0.8808370030478314
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,_VANDETANIB,NEOPLASMS,NCT02530411,Phase 2,0.575139311451479,0.42486068854852094
NC(N)=Nc1nc(CSCCC(N)=NS(N)(=O)=O)cs1,_FAMOTIDINE,COVID-19,NCT04370262,Phase 3,0.25693183835301914,0.7430681616469808
NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,_HYDROCHLOROTHIAZIDE,"OBESITY, MORBID",NCT03476551,,0.2394727609978451,0.7605272390021551
[Cl-].[K+],_POTASSIUM_CHLORIDE,HEART FAILURE,NCT02840799,Phase 2,0.2583446302417432,0.7416553697582572
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,_GEFITINIB,LUNG CANCER,NCT03292133,Phase 2,0.248066152868168,0.7519338471318322
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,_GEFITINIB,NSCLC,NCT02856893,Phase 2,0.0878928901160425,0.9121071098839576
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,_OSIMERTINIB,"CARCINOMA, NON-SMALL-CELL LUNG",NCT03784599,Phase 2,0.34654770880466,0.6534522911953402
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,_OSIMERTINIB,LUNG CANCER,NCT03567642,Phase 1,0.4972309296680729,0.5027690703319272
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,_OSIMERTINIB,NSCLC,NCT02856893,Phase 2,0.2658358249951783,0.7341641750048218
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,_OSIMERTINIB,METASTATIC NON SMALL CELL LUNG CANCER,NCT03497767,Phase 2,0.2304079885990653,0.7695920114009346
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,_CRIZOTINIB,NON SMALL CELL LUNG CANCER,NCT03375242,,0.5500774980498622,0.4499225019501379
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,_CRIZOTINIB,NEOPLASMS,NCT03194893,Phase 3,0.4927847451197023,0.5072152548802977
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,NON SMALL CELL LUNG CANCER,NCT03267654,Phase 2,0.5000901020807852,0.4999098979192149
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.07299069887080621,0.9270093011291936
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_APATINIB,NSCLC,NCT03801200,Phase 2,0.2493161362645485,0.7506838637354515
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,NON SMALL CELL LUNG CANCER,NCT03267654,Phase 2,0.5000901020807852,0.4999098979192149
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,HEPATOCELLULAR CARCINOMA,NCT04411706,Phase 2,0.07299069887080621,0.9270093011291936
N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1,_RIVOCERANIB,NSCLC,NCT03801200,Phase 2,0.2493161362645485,0.7506838637354515
CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,_ALECTINIB,NON SMALL CELL LUNG CANCER,NCT03944772,Phase 2,0.7099096333869774,0.2900903666130226
CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,_ALECTINIB,NEOPLASMS,NCT03194893,Phase 3,0.6331039215854193,0.3668960784145807
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,_ICOTINIB,LUNG CANCER,NCT01996098,Phase 3,0.06069194162903613,0.939308058370964
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,_ICOTINIB,METASTATIC BREAST CANCER,NCT02362230,Phase 2,0.16244410655520242,0.8375558934447976
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,_ICOTINIB,NON-SQUAMOUS NSCLC,NCT03992885,Phase 3,0.15439698762247464,0.8456030123775254
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,_TOPOTECAN,OVARIAN CANCER,NCT03763123,Phase 1,0.6747602139317206,0.32523978606827925
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1,_TOPOTECAN,SMALL CELL LUNG CANCER,NCT03088813,Phase 2|Phase 3,0.8558266594076978,0.14417334059230216
Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1,_TALAZOPARIB,BREAST CANCER,NCT04039230,Phase 1|Phase 2,0.8001942717555312,0.1998057282444688
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_ALBUTEROL,PULMONARY HYPERTENSION,NCT03270332,Early Phase 1,0.003935667540102701,0.9960643324598972
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1,_SALBUTAMOL,PULMONARY HYPERTENSION,NCT03270332,Early Phase 1,0.003935667540102701,0.9960643324598972
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,_QUETIAPINE,"OBESITY, MORBID",NCT03449472,,0.16804185073728806,0.8319581492627119
C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,_APREPITANT,NON SMALL CELL LUNG CANCER,NCT02646020,Phase 2,0.2237527692262962,0.7762472307737041
C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1,_APREPITANT,COVID-19,NCT04470622,Phase 2,0.4069309263446575,0.5930690736553427
CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,_MEGESTROL_ACETATE,BREAST CANCER,NCT03306472,Phase 2,0.3792836221559441,0.6207163778440561
NCCCC[C@H](N)C(=O)O,_LYSINE,HEART FAILURE,NCT03446651,Early Phase 1,0.4169724709390335,0.5830275290609667
Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@H](CCC(=O)[O-])C(=O)[O-])cc3)c2c(=O)[nH]1.[Na+].[Na+],_PEMETREXED_DISODIUM,NON SMALL CELL LUNG CANCER,NCT04379635,Phase 3,0.6064528449325095,0.3935471550674904
CN1CCN2c3ncccc3Cc3ccccc3C2C1,_MIRTAZAPINE,BREAST CANCER,NCT02336750,Phase 3,0.12052864575025547,0.8794713542497444
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,_FUROSEMIDE,NASAL POLYPS,NCT03362515,Phase 2,0.22199910346301016,0.7780008965369899
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C,_ESTROGEN,URINARY TRACT INFECTIONS,NCT04301934,Not Applicable,0.3641036392342551,0.6358963607657451
COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,_TIVOZANIB,HEPATOCELLULAR CARCINOMA,NCT03970616,Phase 1|Phase 2,0.7815939939993997,0.21840600600060012
Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2,_ALPRAZOLAM,TYPE 1 DIABETES,NCT03635437,Phase 1|Phase 2,0.12936742084176625,0.8706325791582339
C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O,_MUPIROCIN,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.4029287910550308,0.5970712089449692
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,BREAST CANCER,NCT02395614,Not Applicable,0.34328950102940736,0.6567104989705926
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,INFECTION,NCT03844776,Not Applicable,0.20287965315827086,0.7971203468417289
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1,_CHLORHEXIDINE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.5046654522836949,0.4953345477163051
N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1.O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,_CHLORHEXIDINE_GLUCONATE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.5292864376848366,0.4707135623151633
Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1,_SULFAMETHOXAZOLE,CYSTIC FIBROSIS,NCT03489629,Phase 2,0.3898880634412301,0.6101119365587699
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,_CEDIRANIB,NON SMALL CELL LUNG CANCER,NCT03334617,Phase 2,0.8038488392279235,0.1961511607720764
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,_BETAMETHASONE,PREMATURE BIRTH,NCT02469519,Phase 2|Phase 3,0.010620311172586695,0.9893796888274132
COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC,_PRAZOSIN,COVID-19,NCT04365257,Phase 2,0.15895453524277564,0.8410454647572245
CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O,_ITRACONAZOLE,LUNG CANCER,NCT03664115,Phase 2,0.08963261394682431,0.9103673860531756
CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O,_PLINABULIN,NON SMALL CELL LUNG CANCER,NCT02504489,Phase 3,0.5502996385920064,0.4497003614079936
CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O,_PLINABULIN,NON-SMALL CELL LUNG CANCER METASTATIC,NCT02812667,Phase 1,0.7937211715926809,0.2062788284073187
CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,_RUCAPARIB,BREAST CANCER,NCT03911453,Early Phase 1,0.582651365093133,0.41734863490686697
CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1,_RUCAPARIB,SMALL CELL LUNG CANCER,NCT03958045,Phase 2,0.582651365093133,0.41734863490686697
O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,_SUGAMMADEX,BURN,NCT03513406,Phase 3,0.08245944113674109,0.9175405588632588
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)SCF,_FLUTICASONE,PHARMACOKINETICS,NCT03739294,Phase 2,0.1050150214067884,0.8949849785932116
[Fe+2].[Fe+3].[Fe+3].[O-2].[O-2].[O-2].[O-2],_FERUMOXYTOL,BRAIN NEOPLASM,NCT03234309,Phase 2,0.5849513250429544,0.4150486749570456
[Fe+2].[Fe+3].[Fe+3].[O-2].[O-2].[O-2].[O-2],_FERUMOXYTOL,PULMONARY EMBOLISM,NCT03173066,Phase 1,0.5328433190040809,0.4671566809959192
Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3,_BUTORPHANOL,AGITATION,NCT03398759,Not Applicable,0.1061981161870358,0.8938018838129641
Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3,_BUTORPHANOL,COLONOSCOPY,NCT04477733,Not Applicable,0.1061981161870358,0.8938018838129641
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-],_NITROGLYCERIN,HYPERTENSION,NCT02425566,Phase 1,0.592080720939311,0.4079192790606889
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT03843125,Phase 3,0.4114569930872573,0.5885430069127427
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,COVID-19,NCT04321993,Phase 2,0.34287370327480593,0.6571262967251941
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,COVID-19 PNEUMONIA,NCT04346147,Phase 2,0.2553063335187253,0.7446936664812749
CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1,_BARICITINIB,ATOPIC DERMATITIS,NCT03952559,Phase 3,0.3782841282817271,0.6217158717182729
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,PROSTATE CANCER,NCT03716739,Phase 2,0.14961549855879913,0.8503845014412009
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,_TESTOSTERONE,LIVER CIRRHOSIS,NCT03995251,Not Applicable,0.06812166255789727,0.9318783374421028
CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1,_KETOCONAZOLE,PROSTATE CANCER,NCT00859781,Phase 2,0.3668767804098359,0.6331232195901643
OC[C@H]1O[C@H](O[C@]2(CO[C@]3(CO[C@]4(CO[C@]5(CO[C@]6(CO[C@]7(CO[C@]8(CO[C@]9(CO[C@]%10(CO[C@]%11(CO[C@]%12(CO[C@]%13(CO[C@]%14(CO[C@]%15(CO[C@]%16(CO[C@]%17(CO[C@]%18(CO[C@]%19(CO[C@]%20(CO[C@]%21(CO[C@]%22(CO[C@]%23(CO[C@]%24(CO[C@]%25(CO[C@]%26(CO[C@]%27(CO[C@]%28(CO[C@]%29(CO[C@]%30(CO[C@]%31(CO[C@]%32(CO[C@]%33(CO[C@]%34(CO[C@]%35(CO[C@]%36(CO[C@]%37(CO[C@]%38(CO)O[C@H](CO)[C@@H](O)[C@@H]%38O)O[C@H](CO)[C@@H](O)[C@@H]%37O)O[C@H](CO)[C@@H](O)[C@@H]%36O)O[C@H](CO)[C@@H](O)[C@@H]%35O)O[C@H](CO)[C@@H](O)[C@@H]%34O)O[C@H](CO)[C@@H](O)[C@@H]%33O)O[C@H](CO)[C@@H](O)[C@@H]%32O)O[C@H](CO)[C@@H](O)[C@@H]%31O)O[C@H](CO)[C@@H](O)[C@@H]%30O)O[C@H](CO)[C@@H](O)[C@@H]%29O)O[C@H](CO)[C@@H](O)[C@@H]%28O)O[C@H](CO)[C@@H](O)[C@@H]%27O)O[C@H](CO)[C@@H](O)[C@@H]%26O)O[C@H](CO)[C@@H](O)[C@@H]%25O)O[C@H](CO)[C@@H](O)[C@@H]%24O)O[C@H](CO)[C@@H](O)[C@@H]%23O)O[C@H](CO)[C@@H](O)[C@@H]%22O)O[C@H](CO)[C@@H](O)[C@@H]%21O)O[C@H](CO)[C@@H](O)[C@@H]%20O)O[C@H](CO)[C@@H](O)[C@@H]%19O)O[C@H](CO)[C@@H](O)[C@@H]%18O)O[C@H](CO)[C@@H](O)[C@@H]%17O)O[C@H](CO)[C@@H](O)[C@@H]%16O)O[C@H](CO)[C@@H](O)[C@@H]%15O)O[C@H](CO)[C@@H](O)[C@@H]%14O)O[C@H](CO)[C@@H](O)[C@@H]%13O)O[C@H](CO)[C@@H](O)[C@@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_INULIN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT04459156,Not Applicable,0.4916438424749795,0.5083561575250205
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,_ADENOSINE,COUGH,NCT03722849,Not Applicable,0.4668593602289058,0.5331406397710942
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,_ADENOSINE,PAROXYSMAL ATRIAL FIBRILLATION,NCT01672346,Phase 3,0.3845777202493565,0.6154222797506438
Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1,_DESLORATADINE,NON SMALL CELL LUNG CANCER,NCT02646020,Phase 2,0.05400293651467632,0.9459970634853238
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,NON SMALL CELL LUNG CANCER,NCT02570815,Phase 1,0.8578361598192769,0.14216384018072284
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,LUNG CANCER,NCT04182152,Not Applicable,0.408199139259591,0.5918008607404089
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,HEPATOCELLULAR CARCINOMA,NCT04258566,Phase 1,0.8474507121078753,0.15254928789212452
CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21,_INDOCYANINE_GREEN,RHEUMATOID ARTHRITIS,NCT02680067,Phase 1,0.8112204685777781,0.1887795314222218
C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-],_GLYCOPYRROLATE,BURN,NCT03513406,Phase 3,0.16171847339070702,0.8382815266092929
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C,_HYDROCORTISONE_ACETATE,DEPRESSION,NCT02837432,Early Phase 1,0.4203250220188509,0.5796749779811494
CC(=O)C(=O)O,_PYRUVATE,PROSTATE CANCER,NCT02913131,Phase 1|Phase 2,0.8554969847889441,0.14450301521105596
CC(=O)C(=O)O,_PYRUVATE,BREAST CANCER,NCT03121989,Phase 1,0.5627765106914113,0.4372234893085888
C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1,_PACRITINIB,BREAST CANCER,NCT04520269,Phase 1|Phase 2,0.6007155306155478,0.39928446938445217
C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1,_LEVOSIMENDAN,"CARDIAC OUTPUT, LOW",NCT04179604,Phase 2|Phase 3,0.2057620832717036,0.7942379167282967
CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O,_ILOPROST,"RESPIRATORY DISTRESS SYNDROME, ADULT",NCT03111212,Phase 3,0.052527886718264326,0.9474721132817358
CN(C)CCC=C1c2ccccc2COc2ccccc21,_DOXEPIN,BREAST CANCER,NCT02447211,Phase 2,0.3864376793569316,0.6135623206430687
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O=S(=O)(O)O,_ALBUTEROL_SULFATE,ASTHMA,NCT03847896,Phase 3,0.17898172818959124,0.8210182718104091
CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,_PIMAVANSERIN,SCHIZOPHRENIA,NCT04531982,Phase 3,0.2633082095975361,0.7366917904024639
Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1,_TOMIVOSERTIB,BREAST CANCER,NCT04261218,Phase 1,0.7477125073435315,0.2522874926564683
CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1,_VISTUSERTIB,NON SMALL CELL LUNG CANCER,NCT03334617,Phase 2,0.772415378357655,0.22758462164234505
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,_QUERCETIN,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT03989271,Phase 1|Phase 2,0.43679101181983,0.5632089881801701
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C,_SEMAGLUTIDE,TYPE 1 DIABETES,NCT03899402,Phase 2|Phase 3,0.40915514047516655,0.5908448595248336
CCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1,_SAPACITABINE,BREAST CANCER,NCT03641755,Phase 1|Phase 2,0.8411555755936402,0.15884442440635982
CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C,_CICLESONIDE,COVID-19,NCT04377711,Phase 3,0.04320029487765737,0.9567997051223424
OC[C@H]1O[C@H](O[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,_SUCROSE,PAIN,NCT04313179,Not Applicable,0.7593884385590561,0.24061156144094384
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,PAIN,NCT04132609,Not Applicable,0.6208279270784502,0.3791720729215496
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,OBSTRUCTIVE SLEEP APNEA,NCT02666781,,0.7409559322387469,0.2590440677612529
O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1,_BIA,ANXIETY,NCT04245501,Not Applicable,0.5916002025116429,0.4083997974883571
CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,_LINOLEIC_ACID,CYSTIC FIBROSIS,NCT04531410,Not Applicable,0.1875459029833441,0.8124540970166559
CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]2CCCN2C(=O)C(C)=O)[C@@H](C)OC(=O)[C@H](Cc2ccc(OC)cc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O,_PLITIDEPSIN,COVID-19,NCT04382066,Phase 1,0.7396524569939088,0.26034754300609125
N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O,_ICATIBANT,COVID-19,NCT04488081,Phase 2,0.4038930464425256,0.5961069535574745
O=[O+][O-],_OZONE,ISCHEMIC HEART DISEASE,NCT03660657,Phase 2|Phase 3,0.21831372703811933,0.7816862729618808
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF,_FLUTICASONE_FUROATE,PHARMACOKINETICS,NCT03739294,Phase 2,0.17595057789633595,0.8240494221036642
OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O,_VILANTEROL,PHARMACOKINETICS,NCT03739294,Phase 2,0.34332102735179504,0.6566789726482049
Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1,_CANAGLIFLOZIN,HEART FAILURE,NCT04252287,Phase 3,0.3045227723124734,0.6954772276875266
[133Xe],_XENON-133,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,NCT03331302,Phase 1|Phase 2,0.617711725142837,0.3822882748571629
CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)c1cnc(-c2ccccc2)c(-c2ccccc2)n1,_SELEXIPAG,"HYPERTENSION, PULMONARY",NCT04175600,Phase 3,0.3381624669129353,0.6618375330870648
O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1,_PIMONIDAZOLE,PROSTATE CANCER,NCT02095249,Not Applicable,0.5579664533448762,0.44203354665512384
O=N[O-],_NITRITE,HEART FAILURE,NCT02713126,Phase 2,0.7248958669970103,0.27510413300298914
O=N[O-].[Na+],_SODIUM_NITRITE,HEART FAILURE,NCT02713126,Phase 2,0.7073425174393805,0.2926574825606195
COC(=O)OCOc1c2n(ccc1=O)N([C@@H]1c3ccccc3SCc3c1ccc(F)c3F)[C@@H]1COCCN1C2=O,_BALOXAVIR_MARBOXIL,INFLUENZA,NCT03969212,Phase 3,0.35817883448944704,0.6418211655105529
O=C1c2c(O)c(=O)ccn2N([C@@H]2c3ccccc3SCc3c2ccc(F)c3F)[C@@H]2COCCN12,_BALOXAVIR,INFLUENZA,NCT03969212,Phase 3,0.4606551837071682,0.5393448162928318
COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O,_GEFAPIXANT,COUGH,NCT04193176,Phase 3,0.719467717555366,0.2805322824446339
COc1cc(C(C)C)c(Oc2cnc(N)nc2N)cc1S(N)(=O)=O,_GEFAPIXANT,CHRONIC COUGH,NCT04525885,Phase 3,0.639742707400073,0.3602572925999269
N[C@@H](CSCC(=O)O)C(=O)O,_CARBOCYSTEINE,BRONCHIECTASIS,NCT04140214,Phase 3,0.3011329874789874,0.6988670125210128
O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1,_DANTROLENE,MULTIPLE SCLEROSIS,NCT03109288,Phase 1|Phase 2,0.5430573667563798,0.4569426332436201
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,_CARIPRAZINE,SCHIZOPHRENIA,NCT03817502,Phase 3,0.4448193851871386,0.5551806148128614
COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,_ENCORAFENIB,NON SMALL CELL LUNG CANCER,NCT03915951,Phase 2,0.5131163558800084,0.4868836441199917
CN1CCC(C(=O)c2cccc(NC(=O)c3c(F)cc(F)cc3F)n2)CC1,_LASMIDITAN,MIGRAINE DISORDERS,NCT04396574,Phase 3,0.4186162658894262,0.5813837341105738
Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1,_ALPELISIB,BREAST CANCER,NCT03056755,Phase 2,0.5670561820998967,0.4329438179001031
COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1,_ERDAFITINIB,METASTATIC BREAST CANCER,NCT03238196,Phase 1,0.6178506467893445,0.38214935321065546
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12,_ERAVACYCLINE,BACTERIAL INFECTIONS,NCT03696550,Phase 1,0.40965897680254815,0.5903410231974521
CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,_DAROLUTAMIDE,PROSTATE CANCER,NCT04136353,Phase 3,0.5053473821973263,0.4946526178026737
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,ATOPIC DERMATITIS,NCT03569293,Phase 3,0.4907381483012093,0.5092618516987908
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12,_UPADACITINIB,SYSTEMIC LUPUS ERYTHEMATOSUS,NCT04451772,Phase 2,0.4886513539043505,0.5113486460956496
C[C@@H]1[C@H](c2ccccc2)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F,_UBROGEPANT,MIGRAINE DISORDERS,NCT04492020,Phase 3,0.6091737067078559,0.390826293292144
